Latitude Uranium Inc. is pleased to announce that shareholders of the Company have overwhelmingly approved the previously announced arrangement involving the Company and Atha Energy Corp. at the Company's special meeting held today. The special. - Veroeffentlicht am 27.02.2024
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) saw a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 717,600 shares, an increase of 39.6% from the January 15th total of 513,900 shares. Based on an average daily volume of 331,300 shares, the short-interest ratio […]
Atha Energy Corp. is pleased to provide an update on its previously announced proposed acquisition transactions with Latitude Uranium Inc. and 92 Energy Limited further to its press release dated 7, 2023. ATHA is pleased to announce that in. - Veroeffentlicht am 25.01.2024
All four shankaracharyas will not attend January 22’s Ram temple inauguration. Who are these venerable Hindu teachers? What is their philosophy? Who was Adi Shankara, whom they trace their legacy to?
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) CEO Mark James Litton sold 4,820 shares of the business’s stock in a transaction that occurred on Friday, January 5th. The stock was sold at an average price of $2.91, for a total value of $14,026.20. Following the sale, the chief executive officer now directly owns 144,397 […]